Kidney fibrosis: from mechanisms to therapeutic medicines

R Huang, P Fu, L Ma - Signal Transduction and Targeted Therapy, 2023 - nature.com
Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney
fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a …

Extracellular vesicles in kidney disease

C Grange, B Bussolati - Nature Reviews Nephrology, 2022 - nature.com
Extracellular vesicles are released by the majority of cell types and circulate in body fluids.
They function as a long-distance cell-to-cell communication mechanism that modulates the …

The roles of tertiary lymphoid structures in chronic diseases

Y Sato, K Silina, M van den Broek, K Hirahara… - Nature Reviews …, 2023 - nature.com
Tertiary lymphoid structures (TLSs) are ectopic lymphoid tissues that drive antigen-specific
immune responses at sites of chronic inflammation. Unlike secondary lymphoid organs such …

[HTML][HTML] Chronic inflammation in chronic kidney disease progression: role of Nrf2

P Stenvinkel, GM Chertow, P Devarajan, A Levin… - Kidney international …, 2021 - Elsevier
Despite recent advances in the management of chronic kidney disease (CKD), morbidity
and mortality rates in these patients remain high. While pressure-mediated injury is a well …

[HTML][HTML] Treatment of diabetic kidney disease: current and future

T Yamazaki, I Mimura, T Tanaka… - … & metabolism journal, 2021 - synapse.koreamed.org
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. However,
only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD …

Mitochondrial dysfunction in diabetic kidney disease

JM Forbes, DR Thorburn - Nature Reviews Nephrology, 2018 - nature.com
Globally, diabetes is the leading cause of chronic kidney disease and end-stage renal
disease, which are major risk factors for cardiovascular disease and death. Despite this …

Lipid accumulation and chronic kidney disease

Z Gai, T Wang, M Visentin, GA Kullak-Ublick, X Fu… - Nutrients, 2019 - mdpi.com
Obesity and hyperlipidemia are the most prevalent independent risk factors of chronic
kidney disease (CKD), suggesting that lipid accumulation in the renal parenchyma is …

Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments

DP Basile, JV Bonventre, R Mehta… - Journal of the …, 2016 - journals.lww.com
Recent clinical studies indicate a strong link between AKI and progression of CKD. The
increasing prevalence of AKI must compel the nephrology community to consider the long …

[HTML][HTML] Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules

J Li, H Liu, S Takagi, K Nitta, M Kitada, SP Srivastava… - JCI insight, 2020 - ncbi.nlm.nih.gov
Abstract Sodium glucose cotransporter 2 (SGLT2) inhibitors are beneficial in halting diabetic
kidney disease; however, the complete mechanisms have not yet been elucidated. The …

Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond

H Zhao, A Alam, AP Soo, AJT George, D Ma - EBioMedicine, 2018 - thelancet.com
Ischemia-reperfusion injury (IRI) during renal transplantation often initiates non-specific
inflammatory responses that can result in the loss of kidney graft viability. However, the long …